Doctors need to be careful when using the anti-HIV drug Kaletra in children, says an Abbott Laboratories letter posted on the US Food and Drug Administration's Web site.
The drug maker wrote the letter after the accidental overdose death of an infant born with HIV, who died nine days after receiving a 6.5 millilitre dose of Kaletra, the Associated Press reported.
In the letter, Abbott reminds doctors that children should receive less than a 5 millilitre dose of Kaletra oral solution.
"Special attention must be paid to accurate calculation of the dose, transcription of the medication order, dispensing information and dosing instructions to minimise the risk of medication," the letter states.
Kaletra prevents reproduction of HIV, the virus that causes Aids. – (HealthDayNews)